Liberty Capital Management’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-2,130
Closed -$571K 114
2016
Q1
$571K Sell
2,130
-46
-2% -$12.3K 0.43% 61
2015
Q4
$680K Hold
2,176
0.51% 58
2015
Q3
$591K Sell
2,176
-369
-14% -$100K 0.47% 63
2015
Q2
$772K Buy
+2,545
New +$772K 0.52% 61
2015
Q1
Sell
-12,955
Closed -$2.75M 107
2014
Q4
$2.75M Sell
12,955
-200
-2% -$39.8K 1.91% 15
2014
Q3
$2.34M Sell
13,155
-1,260
-9% -$209K 1.7% 20
2014
Q2
$2.44M Sell
14,415
-3,790
-21% -$590K 1.72% 19
2014
Q1
$2.26M Sell
18,205
-245
-1% -$29.8K 1.66% 20
2013
Q4
$2.05M Hold
18,450
1.46% 26
2013
Q3
$1.67M Buy
18,450
+540
+3% +$48.5K 1.32% 31
2013
Q2
$1.51M Buy
+17,910
New +$1.86M 1.3% 32

Other funds holding AGN

Liberty Capital Management's AGN Position: Q2 2016 in Review

Liberty Capital Management sold out of Allergan Inc (AGN) in Q2 2016, closing a stake of 2,130 shares — an estimated $571K sold.

Liberty Capital Management first reported a position in AGN in Q2 2013 and held it in 11 quarters. The position peaked at $2.75M in Q4 2014. 13 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Liberty Capital Management reported no remaining Allergan Inc position as of Q2 2016 after selling out during the quarter.
  • Liberty Capital Management sold 2,130 Allergan Inc shares in Q2 2016, an estimated $571K.
  • Liberty Capital Management first reported a position in Allergan Inc in Q2 2013 and held it in 11 quarters.
  • Liberty Capital Management's Allergan Inc position peaked at $2.75M in Q4 2014.
  • 13 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2016.

Based on Liberty Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.